Italian Guidelines in diagnosis and treatment of alopecia areataAlfredo Rossi, Cosimo Misciali, Annunziata Dattola et al.|Giornale Italiano di Dermatologia e Venereologia|2019Cited by 88
Characteristic of chronic plaque psoriasis patients treated with biologics in Italy during the COVID-19 Pandemic: Risk analysis from the PSO-BIO-COVID observational studyMarina Talamonti, Luca Bianchi, Angelo Valerio Marzano et al.|Expert Opinion on Biological Therapy|2020Cited by 43
Management of biological therapies for chronic plaque psoriasis during COVID‐19 emergency in ItalyMarina Talamonti, Luca Bianchi, Angelo Valerio Marzano et al.|Journal of the European Academy of Dermatology and Venereology|2020Cited by 32
Comparative effectiveness of tildrakizumab 200 mg versus tildrakizumab 100 mg in psoriatic patients with high disease burden or above 90 kg of body weight: a 16-week multicenter retrospective study – IL PSO (Italian landscape psoriasis)Luigi Gargiulo, Alessandra Narcisi, Diego Orsini et al.|Journal of Dermatological Treatment|2024Cited by 21